Results 191 to 200 of about 2,605,313 (261)

Predicting postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: retrospective cohort study. [PDF]

BJS Open
Martin-Roman L, Kusamura S, Guaglio M, Colletti G, Cavalleri T, Deraco M, Baratti D.   +6 more
europepmc   +1 more source

Enhanced recovery after surgery protocols in gastrectomy with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer. [PDF]

World J Clin Oncol
Nampoolsuksan C, Parakonthun T.
europepmc   +1 more source

Anastomosis versus rectal stump procedure in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal peritoneal metastases: A comparative study. [PDF]

Colorectal Dis
Ghanipour L, Mahmmud LO, Cashin P, Palmer GJ, Abraham-Nordling M.   +4 more
europepmc   +1 more source

Splenectomy during cytoreductive surgery in advanced epithelial ovarian cancer can be predicted. [PDF]

Eur J Obstet Gynecol Reprod Biol X
Do TK, Dabi Y, Touboul C, Uzan J, Margueuritte F, Canlorbe G, Kerbage Y, Lavoué V, Akladios C, Ouldamer L, Costaz H, Bricou A, Azaïs H, Chauvet P, Carcopino X, Huchon C, Mimoun C.   +16 more
europepmc   +1 more source

Interval Cytoreductive Surgery and Cisplatin- or Paclitaxel-Based HIPEC for Advanced Ovarian Cancer.

JAMA Netw Open
González Sánchez S, García Fernández J, Cascales-Campos PA, Gonzalez Gil A, Manzanedo I, Pereira Perez F, Díaz Gómez D, González-de Pedro C, Asensio Diaz E, Pacheco Sanchez D, Prada-Villaverde A, Jaén Torrejimeno I, Lacueva J, Caravaca-Garcia I, Torres-Melero J, Sanchez-García S, Díaz Reques E, Ramírez Plaza C, Gutiérrez-Calvo A, González Bayón L, Morales-Soriano R, López-Mozos F, Bjelic L, Galindo Álvarez J, Marcello Fernandez ME, Turienzo Santos E, Titos García A, Álvarez Seoane R, Artiles Armas M, Garaulet ET, Villarejo Campos P, Boldó Roda E, Rihuete Caro C, García Fadrique A, Arjona-Sánchez Á, REGECOP collaborators.   +35 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis.

Journal of Clinical Oncology, 2023
PURPOSE To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy.
R. Bristow, Rafael S. Tomacruz, D. Armstrong, E. Trimble, F. Montz   +4 more
semanticscholar   +1 more source

Cytoreductive Surgery

2022
Alexander B. Olawaiye, Ritu Salani
  +8 more sources

Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).

British Journal of Surgery, 2021
BACKGROUND The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. The prognosis for patients with peritoneal metastases remains poor and the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is ...
P. Bonnot, A. Lintis, F. Mercier, N. Benzerdjeb, G. Passot, M. Pocard, B. Meunier, J. Bereder, K. Abboud, F. Marchal, F. Quénet, D. Goéré, S. Msika, C. Arvieux, N. Pirró, R. Wernert, P. Rat, J. Gagnière, J. Lefèvre, T. Courvoisier, R. Kianmanesh, D. Vaudoyer, M. Rivoire, P. Meeus, L. Villeneuve, G. Piessen, O. Glehen   +26 more
semanticscholar   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review

Diseases of the Colon & Rectum, 2021
BACKGROUND: Combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is emerging as an alternative option for colorectal peritoneal metastases, but there is ambiguity regarding patient selection, treatment ...
Manas Parikh, Paul Johnson, J. Romanes, H. Freitag, M. Spring, N. Garcia-Henriquez, J. Monson   +6 more
semanticscholar   +1 more source

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience

Journal of Surgical Oncology, 2021
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is predominantly performed and studied in academic centers. While developing CRS/HIPEC programs in nonacademic hospitals can increase accessibility, its safety and ...
A. Nikiforchin, V. Gushchin, M. King, E. Baron, C. Nieroda, M. Sittig, A. Sardi   +6 more
semanticscholar   +1 more source